Dayno Jeffrey M. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$4.92M

Insider Activity of Dayno Jeffrey M.

According to the SEC Form 4 filings, Dayno Jeffrey M., being in a position of

  1. PRESIDENT, CEO at Harmony Biosciences Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5933 shares for $237,957,
    over all time since 2021-07-22, has bought 0 shares, and sold 137026 shares for $5.16M.

Biography of Dayno Jeffrey M.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$237,9571100

Comparison of Insiders on Amount of Buys and Sells

2025-12-12SaleHarmony Biosciences Holdings, Inc.
HRMY
PRESIDENT, CEO
5,933
0.0102%
$40.11$237,957-11.06%
2025-01-21SaleHarmony Biosciences Holdings, Inc.
HRMY
PRESIDENT, CEO
19,293
0.0335%
$40.13$774,245-15.37%
2022-11-03SaleHarmony Biosciences Holdings, Inc.
HRMY
CHIEF MEDICAL OFFICER
15,000
0.0254%
$60.02$900,332-39.79%
2022-11-01SaleHarmony Biosciences Holdings, Inc.
HRMY
CHIEF MEDICAL OFFICER
15,000
0.0236%
$55.10$826,559-38.86%
2021-10-19SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
18,200
0.0327%
$43.27$787,543+4.65%
2021-10-06SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
3,600
0.0064%
$40.10$144,357+10.15%
2021-09-07SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
20,000
0.021%
$22.90$457,983+12.41%
2021-08-27SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
15,682
0.0271%
$35.16$551,401+18.8%
2021-08-26SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
4,318
0.0047%
$21.61$93,328+21.71%
2021-08-10SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
19,900
0.022%
$19.22$382,423+35.73%
2021-07-22SaleHarmony Biosciences Holdings, Inc.
HRMY
Chief Medical Officer
100
0.0001%
$19.11$1,911+35.86%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.